These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27717188)

  • 1. Preliminary Investigation of Cardiovascular-Renal Disorders in Dogs with Chronic Mitral Valve Disease.
    Martinelli E; Locatelli C; Bassis S; Crosara S; Paltrinieri S; Scarpa P; Spalla I; Zanaboni AM; Quintavalla C; Brambilla P
    J Vet Intern Med; 2016 Sep; 30(5):1612-1618. PubMed ID: 27717188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron status in dogs with myxomatous mitral valve disease.
    Savarese A; Probo M; Locatelli C; Gazzonis AL; Zanzani SA; Traini G; Vitiello T; Brambilla PG
    Pol J Vet Sci; 2018 Sep; 21(3):507-515. PubMed ID: 30468339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitral valve reconstruction in a toy-breed dog.
    Boggs LS; Dewan SJ; Ballard SE
    J Am Vet Med Assoc; 1996 Dec; 209(11):1872-6. PubMed ID: 8944800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs.
    Szczepankiewicz B; Pasławska U; Siwińska N; Plens K; Pasławski R
    J Renin Angiotensin Aldosterone Syst; 2021; 22(1):1470320321995082. PubMed ID: 33730896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of atorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease.
    Cunningham SM; Rush JE; Freeman LM
    J Vet Intern Med; 2013; 27(4):985-9. PubMed ID: 23758137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.
    Keene BW; Atkins CE; Bonagura JD; Fox PR; Häggström J; Fuentes VL; Oyama MA; Rush JE; Stepien R; Uechi M
    J Vet Intern Med; 2019 May; 33(3):1127-1140. PubMed ID: 30974015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
    Yata M; Kooistra HS; Beijerink NJ
    J Vet Intern Med; 2019 Mar; 33(2):462-470. PubMed ID: 30703246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Prognosis of Anemia in Dogs with Degenerative Mitral Valve Disease.
    Yu IB; Huang HP
    Biomed Res Int; 2016; 2016():4727054. PubMed ID: 27840827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial function in small dogs with chronic mitral regurgitation and severe congestive heart failure.
    Kittleson MD; Eyster GE; Knowlen GG; Bari Olivier N; Anderson LK
    J Am Vet Med Assoc; 1984 Feb; 184(4):455-9. PubMed ID: 6698877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
    Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D
    Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the histopathologic pattern of the left atrium in canine dilated cardiomyopathy and chronic mitral valve disease.
    Janus I; Noszczyk-Nowak A; Nowak M; Ciaputa R; Kandefer-Gola M; Pasławska U
    BMC Vet Res; 2016 Jan; 12():3. PubMed ID: 26728624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy.
    Schober KE; Hart TM; Stern JA; Li X; Samii VF; Zekas LJ; Scansen BA; Bonagura JD
    J Am Vet Med Assoc; 2011 Aug; 239(4):468-79. PubMed ID: 21838584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
    Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
    J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy.
    Ware WA; Lund DD; Subieta AR; Schmid PG
    J Am Vet Med Assoc; 1990 Dec; 197(11):1475-81. PubMed ID: 2272879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiac biomarker sodium-calcium exchanger (NCX-1) can differentiate between heart failure and renal failure: a comparative study of NCX-1 expression in dogs with chronic mitral valvular insufficiency and azotemia.
    Nam SJ; Han SH; Kim HW; Hyun C
    J Vet Intern Med; 2010; 24(6):1383-7. PubMed ID: 21054542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical findings and survival time in dogs with advanced heart failure.
    Beaumier A; Rush JE; Yang VK; Freeman LM
    J Vet Intern Med; 2018 May; 32(3):944-950. PubMed ID: 29635788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic regurgitant orifice area obtained using 3D-echocardiography as an indicator of severity of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Müller S; Menciotti G; Borgarelli M
    J Vet Cardiol; 2017 Oct; 19(5):433-440. PubMed ID: 28964709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of progression of chronic kidney disease in dogs with myxomatous mitral valve disease.
    Yun H; Koo Y; Yun T; Chae Y; Lee D; Cha S; Kim J; Kim H; Yang MP; Kang BT
    Front Vet Sci; 2023; 10():1200653. PubMed ID: 37691634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.